Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steven

Showing results (401-410 of 440) with videos related to

Pageof 44
Sort By:
Lancet (London, England)|December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trialsXavier Sáez-Llorens, Ananda S Bandyopadhyay, Christopher Gast, et al.
The Lancet. Microbe|November 4, 2022
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trialsRahnuma Wahid, Laina D Mercer, Tirza De Leon, et al.
Journal of the American Heart Association|September 23, 2020
Decreasing Interstage Mortality After the Norwood Procedure: A 30-Year ExperienceMichelle Kaplinski, Richard F Ittenbach, Mallory L Hunt, et al.
Pediatrics|June 19, 2013
"Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreakErin F Mathes, Vikash Oza, Ilona J Frieden, et al.
Vaccine|August 31, 2023
Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trialCynthia J Snider, Khalequ Zaman, Amanda L Wilkinson, et al.
Lancet (London, England)|May 24, 2016
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trialEdwin J Asturias, Ananda S Bandyopadhyay, Steve Self, et al.
NPJ Vaccines|July 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine virusesRahnuma Wahid, Laina Mercer, Andrew Macadam, et al.
The Lancet. Infectious Diseases|December 21, 2019
Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort studyKevin Messacar, Emily Spence-Davizon, Christina Osborne, et al.
The Annals of Thoracic Surgery|September 28, 2015
Improving Cardiac Surgical Site Infection Reporting and Prevention By Using Registry Data for Case AscertainmentVaidehi Nayar, Andrea Kennedy, Janine Pappas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2016
Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide SurveillanceJames J Sejvar, Adriana S Lopez, Margaret M Cortese, et al.
Pageof 44

Showing results (401-410 of 440) with videos related to

Sort By:
Pageof 44
Lancet (London, England)|December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trialsXavier Sáez-Llorens, Ananda S Bandyopadhyay, Christopher Gast, et al.
The Lancet. Microbe|November 4, 2022
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trialsRahnuma Wahid, Laina D Mercer, Tirza De Leon, et al.
Journal of the American Heart Association|September 23, 2020
Decreasing Interstage Mortality After the Norwood Procedure: A 30-Year ExperienceMichelle Kaplinski, Richard F Ittenbach, Mallory L Hunt, et al.
Pediatrics|June 19, 2013
"Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreakErin F Mathes, Vikash Oza, Ilona J Frieden, et al.
Vaccine|August 31, 2023
Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trialCynthia J Snider, Khalequ Zaman, Amanda L Wilkinson, et al.
Lancet (London, England)|May 24, 2016
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trialEdwin J Asturias, Ananda S Bandyopadhyay, Steve Self, et al.
NPJ Vaccines|July 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine virusesRahnuma Wahid, Laina Mercer, Andrew Macadam, et al.
The Lancet. Infectious Diseases|December 21, 2019
Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort studyKevin Messacar, Emily Spence-Davizon, Christina Osborne, et al.
The Annals of Thoracic Surgery|September 28, 2015
Improving Cardiac Surgical Site Infection Reporting and Prevention By Using Registry Data for Case AscertainmentVaidehi Nayar, Andrea Kennedy, Janine Pappas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2016
Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide SurveillanceJames J Sejvar, Adriana S Lopez, Margaret M Cortese, et al.
Pageof 44